These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16008161)

  • 21. Clinical genetics of Parkinson's disease and related disorders.
    Wider C; Wszolek ZK
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA; Harper JD; Lansbury PT
    Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lewy bodies, a misleading marker for Parkinson's disease?].
    Duyckaerts C; Hauw JJ
    Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathology of familial Parkinson's disease].
    Wakabayashi K; Takahashi H
    Brain Nerve; 2007 Aug; 59(8):851-64. PubMed ID: 17713121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common variants of LRRK2 are not associated with sporadic Parkinson's disease.
    Biskup S; Mueller JC; Sharma M; Lichtner P; Zimprich A; Berg D; Wüllner U; Illig T; Meitinger T; Gasser T
    Ann Neurol; 2005 Dec; 58(6):905-8. PubMed ID: 16254973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of recent genetic findings in Parkinson's disease.
    Klein C; Lohmann-Hedrich K
    Curr Opin Neurol; 2007 Aug; 20(4):453-64. PubMed ID: 17620882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on pathogenesis of Parkinson's disease].
    Mizuno Y
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():66-70. PubMed ID: 15796059
    [No Abstract]   [Full Text] [Related]  

  • 29. [What can we learn from genes responsible for familial forms of Parkinson's disease?].
    Brice A
    Bull Acad Natl Med; 2006 Feb; 190(2):485-96; discussion 497-8. PubMed ID: 17001874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of Parkinson's disease: LRRK2 on the rise.
    Brice A
    Brain; 2005 Dec; 128(Pt 12):2760-2. PubMed ID: 16311269
    [No Abstract]   [Full Text] [Related]  

  • 31. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
    Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
    Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
    Iwatsubo T
    J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraneuronal Lewy body inclusions in Parkinson and diffuse Lewy body disease.
    Bogdanovic N
    J Cell Mol Med; 2001; 5(3):318-9. PubMed ID: 12067491
    [No Abstract]   [Full Text] [Related]  

  • 34. How much does dardarin contribute to Parkinson's disease?
    Brice A
    Lancet; 2005 Jan 29-Feb 4; 365(9457):363-4. PubMed ID: 15680438
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease.
    Melrose HL; Kent CB; Taylor JP; Dachsel JC; Hinkle KM; Lincoln SJ; Mok SS; Culvenor JG; Masters CL; Tyndall GM; Bass DI; Ahmed Z; Andorfer CA; Ross OA; Wszolek ZK; Delldonne A; Dickson DW; Farrer MJ
    Neuroscience; 2007 Jul; 147(4):1047-58. PubMed ID: 17611037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease.
    Scherzer CR; Jensen RV; Gullans SR; Feany MB
    Hum Mol Genet; 2003 Oct; 12(19):2457-66. PubMed ID: 12915459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinson's disease: a broken nosology.
    Hardy J; Lees AJ
    Mov Disord; 2005 Aug; 20 Suppl 12():S2-4. PubMed ID: 16092073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticipation of onset age in familial Parkinson's disease without SCA gene mutations.
    Huang Y; Hayes M; Harding AJ; Brooks WS; Fung VS; Rowe D; Joffe R; Crimmins D; Hely M; Halliday GM
    Parkinsonism Relat Disord; 2006 Jun; 12(5):309-13. PubMed ID: 16621662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease.
    Haubenberger D; Bonelli S; Hotzy C; Leitner P; Lichtner P; Samal D; Katzenschlager R; Djamshidian A; Brücke T; Steffelbauer M; Bancher C; Grossmann J; Ransmayr G; Strom TM; Meitinger T; Gasser T; Auff E; Zimprich A
    Mov Disord; 2007 Aug; 22(11):1640-3. PubMed ID: 17523199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.